These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12915159)

  • 21. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.
    Nurmohamed MT; van Halm VP; Dijkmans BA
    Drugs; 2002; 62(11):1599-609. PubMed ID: 12109923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheumatoid arthritis: developing pharmacological therapies.
    Misischia RJ; Moreland LW
    Expert Opin Investig Drugs; 2002 Jul; 11(7):927-35. PubMed ID: 12084003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future.
    Kim GW; Lee NR; Pi RH; Lim YS; Lee YM; Lee JM; Jeong HS; Chung SH
    Arch Pharm Res; 2015; 38(5):575-84. PubMed ID: 25648633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and therapy of rheumatoid arthritis].
    Müller-Ladner U; Rüther W; Burmester GR
    Dtsch Med Wochenschr; 2004 Jun; 129(23):1318-21. PubMed ID: 15179592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response.
    Gibbons LJ; Hyrich KL
    BioDrugs; 2009; 23(2):111-24. PubMed ID: 19489652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of selective cyclooxygenase-2 inhibition.
    Emery P
    Scand J Rheumatol Suppl; 1996; 102():23-8. PubMed ID: 8628978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and future drug therapies for rheumatoid arthritis.
    Simon LS; Yocum D
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():36-42. PubMed ID: 11001378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arthritis: new agents herald more effective symptom management.
    Simon LS
    Geriatrics; 1999 Jun; 54(6):37-42; quiz 44. PubMed ID: 10377916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterisation of CR6086, a potent prostaglandin E
    Caselli G; Bonazzi A; Lanza M; Ferrari F; Maggioni D; Ferioli C; Giambelli R; Comi E; Zerbi S; Perrella M; Letari O; Di Luccio E; Colovic M; Persiani S; Zanelli T; Mennuni L; Piepoli T; Rovati LC
    Arthritis Res Ther; 2018 Mar; 20(1):39. PubMed ID: 29490676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How is it best to treat early rheumatoid arthritis patients?
    O'Dell JR
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):125-37. PubMed ID: 11358419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of rheumatoid arthritis.
    Jain R; Lipsky PE
    Med Clin North Am; 1997 Jan; 81(1):57-84. PubMed ID: 9012755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on treatment of rheumatoid arthritis.
    Schuna AA
    J Am Pharm Assoc (Wash); 1998; 38(6):728-35; quiz 735-7. PubMed ID: 9861791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical therapeutics.
    Robinson DR
    Curr Opin Rheumatol; 1999 May; 11(3):159-60. PubMed ID: 10328572
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-arthritic agents: progress and potential.
    Laev SS; Salakhutdinov NF
    Bioorg Med Chem; 2015 Jul; 23(13):3059-80. PubMed ID: 26014481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 36. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.
    Salliot C; Finckh A; Katchamart W; Lu Y; Sun Y; Bombardier C; Keystone E
    Ann Rheum Dis; 2011 Feb; 70(2):266-71. PubMed ID: 21097801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment strategies for rheumatoid arthritis.
    Matteson EL
    Mayo Clin Proc; 2000 Jan; 75(1):69-74. PubMed ID: 10630759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic approaches for rheumatoid arthritis.
    Abdelaty EM; Schumacher HR
    Int J Clin Pract; 1999; 53(7):535-9. PubMed ID: 10692740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis.
    Bae SC; Corzillius M; Kuntz KM; Liang MH
    Rheumatology (Oxford); 2003 Jan; 42(1):46-53. PubMed ID: 12509612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of rheumatoid arthritis].
    Bolten WW
    MMW Fortschr Med; 2008 Aug; 150(32-35):50-3; quiz 54. PubMed ID: 19006884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.